venBio Global Strategic Fund III, L.P. insider trades: Artiva Biotherapeutics (ARTV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where venBio Global Strategic Fund III, L.P. reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | ARTV | ↑ Buy | 416,666 | $12.00 | $5.0M | Direct | Jul 22, 2024 (0d) |
| May 25, 2022 | ELEV | ↓ Sell | 702,737 | $4.12 | $2.9M | Direct | May 27, 2022 (2d) |
| Oct 25, 2021 | VTYX | ↑ Buy | 312,500 | $16.00 | $5.0M | Direct | Oct 25, 2021 (0d) |
| Jun 29, 2021 | ELEV | ↑ Buy | 625,000 | $16.00 | $10.0M | Direct | Jul 1, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARTV insiders
Open-market trades in the last 12 months
About venBio Global Strategic Fund III, L.P.'s insider trades
venBio Global Strategic Fund III, L.P. is an insider at Artiva Biotherapeutics (ARTV). Since Jun 29, 2021, it has reported 3 open-market purchases worth $20.0M and 1 sale worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARTV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.